nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—ABCB1—Linagliptin—type 2 diabetes mellitus	0.191	0.277	CbGbCtD
Sofosbuvir—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.17	0.247	CbGbCtD
Sofosbuvir—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.123	0.179	CbGbCtD
Sofosbuvir—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0846	0.123	CbGbCtD
Sofosbuvir—ABCB1—Glyburide—type 2 diabetes mellitus	0.063	0.0914	CbGbCtD
Sofosbuvir—ABCB1—Losartan—type 2 diabetes mellitus	0.0576	0.0836	CbGbCtD
Sofosbuvir—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000468	0.00151	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000462	0.00149	CcSEcCtD
Sofosbuvir—Chills—Irbesartan—type 2 diabetes mellitus	0.00046	0.00148	CcSEcCtD
Sofosbuvir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000459	0.00148	CcSEcCtD
Sofosbuvir—Infection—Gliclazide—type 2 diabetes mellitus	0.000458	0.00148	CcSEcCtD
Sofosbuvir—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000458	0.00147	CcSEcCtD
Sofosbuvir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000456	0.00147	CcSEcCtD
Sofosbuvir—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000454	0.00146	CcSEcCtD
Sofosbuvir—Cough—Valsartan—type 2 diabetes mellitus	0.000453	0.00146	CcSEcCtD
Sofosbuvir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000453	0.00146	CcSEcCtD
Sofosbuvir—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000452	0.00146	CcSEcCtD
Sofosbuvir—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000452	0.00146	CcSEcCtD
Sofosbuvir—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000448	0.00144	CcSEcCtD
Sofosbuvir—Cough—Orlistat—type 2 diabetes mellitus	0.000448	0.00144	CcSEcCtD
Sofosbuvir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000447	0.00144	CcSEcCtD
Sofosbuvir—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000446	0.00144	CcSEcCtD
Sofosbuvir—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000446	0.00144	CcSEcCtD
Sofosbuvir—Vision blurred—Metformin—type 2 diabetes mellitus	0.000445	0.00143	CcSEcCtD
Sofosbuvir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000445	0.00143	CcSEcCtD
Sofosbuvir—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000444	0.00143	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000443	0.00143	CcSEcCtD
Sofosbuvir—Myalgia—Valsartan—type 2 diabetes mellitus	0.000442	0.00142	CcSEcCtD
Sofosbuvir—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000442	0.00142	CcSEcCtD
Sofosbuvir—Chest pain—Valsartan—type 2 diabetes mellitus	0.000442	0.00142	CcSEcCtD
Sofosbuvir—Dizziness—Glipizide—type 2 diabetes mellitus	0.000441	0.00142	CcSEcCtD
Sofosbuvir—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00044	0.00142	CcSEcCtD
Sofosbuvir—Anxiety—Valsartan—type 2 diabetes mellitus	0.00044	0.00142	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000439	0.00141	CcSEcCtD
Sofosbuvir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000437	0.00141	CcSEcCtD
Sofosbuvir—Chest pain—Orlistat—type 2 diabetes mellitus	0.000437	0.00141	CcSEcCtD
Sofosbuvir—Myalgia—Orlistat—type 2 diabetes mellitus	0.000437	0.00141	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000436	0.0014	CcSEcCtD
Sofosbuvir—Anxiety—Orlistat—type 2 diabetes mellitus	0.000435	0.0014	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000434	0.0014	CcSEcCtD
Sofosbuvir—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000432	0.00139	CcSEcCtD
Sofosbuvir—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000429	0.00138	CcSEcCtD
Sofosbuvir—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000427	0.00138	CcSEcCtD
Sofosbuvir—Alopecia—Losartan—type 2 diabetes mellitus	0.000426	0.00137	CcSEcCtD
Sofosbuvir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000426	0.00137	CcSEcCtD
Sofosbuvir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000425	0.00137	CcSEcCtD
Sofosbuvir—Vomiting—Glipizide—type 2 diabetes mellitus	0.000424	0.00137	CcSEcCtD
Sofosbuvir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000423	0.00136	CcSEcCtD
Sofosbuvir—Infection—Valsartan—type 2 diabetes mellitus	0.000421	0.00136	CcSEcCtD
Sofosbuvir—Rash—Glipizide—type 2 diabetes mellitus	0.000421	0.00135	CcSEcCtD
Sofosbuvir—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00042	0.00135	CcSEcCtD
Sofosbuvir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00042	0.00135	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00042	0.00135	CcSEcCtD
Sofosbuvir—Headache—Glipizide—type 2 diabetes mellitus	0.000418	0.00135	CcSEcCtD
Sofosbuvir—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000417	0.00134	CcSEcCtD
Sofosbuvir—Infection—Orlistat—type 2 diabetes mellitus	0.000416	0.00134	CcSEcCtD
Sofosbuvir—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000415	0.00134	CcSEcCtD
Sofosbuvir—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000412	0.00133	CcSEcCtD
Sofosbuvir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000412	0.00133	CcSEcCtD
Sofosbuvir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000411	0.00133	CcSEcCtD
Sofosbuvir—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000411	0.00132	CcSEcCtD
Sofosbuvir—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00041	0.00132	CcSEcCtD
Sofosbuvir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00041	0.00132	CcSEcCtD
Sofosbuvir—Agitation—Irbesartan—type 2 diabetes mellitus	0.00041	0.00132	CcSEcCtD
Sofosbuvir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000407	0.00131	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000406	0.00131	CcSEcCtD
Sofosbuvir—Back pain—Losartan—type 2 diabetes mellitus	0.000406	0.00131	CcSEcCtD
Sofosbuvir—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000406	0.00131	CcSEcCtD
Sofosbuvir—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000404	0.0013	CcSEcCtD
Sofosbuvir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000403	0.0013	CcSEcCtD
Sofosbuvir—Myalgia—Metformin—type 2 diabetes mellitus	0.000402	0.0013	CcSEcCtD
Sofosbuvir—Chest pain—Metformin—type 2 diabetes mellitus	0.000402	0.0013	CcSEcCtD
Sofosbuvir—Headache—Pioglitazone—type 2 diabetes mellitus	0.0004	0.00129	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.0004	0.00129	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000398	0.00128	CcSEcCtD
Sofosbuvir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000397	0.00128	CcSEcCtD
Sofosbuvir—Nausea—Glipizide—type 2 diabetes mellitus	0.000396	0.00128	CcSEcCtD
Sofosbuvir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000396	0.00128	CcSEcCtD
Sofosbuvir—Vision blurred—Losartan—type 2 diabetes mellitus	0.000396	0.00127	CcSEcCtD
Sofosbuvir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000395	0.00127	CcSEcCtD
Sofosbuvir—Pain—Gliclazide—type 2 diabetes mellitus	0.000394	0.00127	CcSEcCtD
Sofosbuvir—Constipation—Gliclazide—type 2 diabetes mellitus	0.000394	0.00127	CcSEcCtD
Sofosbuvir—Rash—Glimepiride—type 2 diabetes mellitus	0.000393	0.00126	CcSEcCtD
Sofosbuvir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000392	0.00126	CcSEcCtD
Sofosbuvir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000391	0.00126	CcSEcCtD
Sofosbuvir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000391	0.00126	CcSEcCtD
Sofosbuvir—Headache—Glimepiride—type 2 diabetes mellitus	0.00039	0.00126	CcSEcCtD
Sofosbuvir—Cough—Irbesartan—type 2 diabetes mellitus	0.000389	0.00125	CcSEcCtD
Sofosbuvir—Headache—Sitagliptin—type 2 diabetes mellitus	0.000389	0.00125	CcSEcCtD
Sofosbuvir—Anaemia—Losartan—type 2 diabetes mellitus	0.000388	0.00125	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000386	0.00124	CcSEcCtD
Sofosbuvir—Agitation—Losartan—type 2 diabetes mellitus	0.000386	0.00124	CcSEcCtD
Sofosbuvir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000384	0.00124	CcSEcCtD
Sofosbuvir—Infection—Metformin—type 2 diabetes mellitus	0.000383	0.00123	CcSEcCtD
Sofosbuvir—Insomnia—Valsartan—type 2 diabetes mellitus	0.000383	0.00123	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000381	0.00123	CcSEcCtD
Sofosbuvir—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00038	0.00122	CcSEcCtD
Sofosbuvir—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00038	0.00122	CcSEcCtD
Sofosbuvir—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00038	0.00122	CcSEcCtD
Sofosbuvir—Insomnia—Orlistat—type 2 diabetes mellitus	0.000379	0.00122	CcSEcCtD
Sofosbuvir—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000378	0.00122	CcSEcCtD
Sofosbuvir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000378	0.00122	CcSEcCtD
Sofosbuvir—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000378	0.00122	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000377	0.00121	CcSEcCtD
Sofosbuvir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000375	0.00121	CcSEcCtD
Sofosbuvir—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000373	0.0012	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000373	0.0012	CcSEcCtD
Sofosbuvir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000371	0.0012	CcSEcCtD
Sofosbuvir—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000371	0.0012	CcSEcCtD
Sofosbuvir—Nausea—Glimepiride—type 2 diabetes mellitus	0.00037	0.00119	CcSEcCtD
Sofosbuvir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000369	0.00119	CcSEcCtD
Sofosbuvir—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000368	0.00119	CcSEcCtD
Sofosbuvir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000368	0.00119	CcSEcCtD
Sofosbuvir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000368	0.00119	CcSEcCtD
Sofosbuvir—Cough—Losartan—type 2 diabetes mellitus	0.000366	0.00118	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000366	0.00118	CcSEcCtD
Sofosbuvir—Alopecia—Ramipril—type 2 diabetes mellitus	0.000365	0.00118	CcSEcCtD
Sofosbuvir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000365	0.00118	CcSEcCtD
Sofosbuvir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000364	0.00117	CcSEcCtD
Sofosbuvir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000364	0.00117	CcSEcCtD
Sofosbuvir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000363	0.00117	CcSEcCtD
Sofosbuvir—Constipation—Valsartan—type 2 diabetes mellitus	0.000362	0.00117	CcSEcCtD
Sofosbuvir—Infection—Irbesartan—type 2 diabetes mellitus	0.000362	0.00116	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000361	0.00116	CcSEcCtD
Sofosbuvir—Fatigue—Orlistat—type 2 diabetes mellitus	0.000361	0.00116	CcSEcCtD
Sofosbuvir—Malnutrition—Ramipril—type 2 diabetes mellitus	0.00036	0.00116	CcSEcCtD
Sofosbuvir—Pain—Orlistat—type 2 diabetes mellitus	0.000358	0.00115	CcSEcCtD
Sofosbuvir—Arthralgia—Losartan—type 2 diabetes mellitus	0.000357	0.00115	CcSEcCtD
Sofosbuvir—Myalgia—Losartan—type 2 diabetes mellitus	0.000357	0.00115	CcSEcCtD
Sofosbuvir—Chest pain—Losartan—type 2 diabetes mellitus	0.000357	0.00115	CcSEcCtD
Sofosbuvir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000357	0.00115	CcSEcCtD
Sofosbuvir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000357	0.00115	CcSEcCtD
Sofosbuvir—Anxiety—Losartan—type 2 diabetes mellitus	0.000356	0.00115	CcSEcCtD
Sofosbuvir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000354	0.00114	CcSEcCtD
Sofosbuvir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000354	0.00114	CcSEcCtD
Sofosbuvir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000354	0.00114	CcSEcCtD
Sofosbuvir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000352	0.00113	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000351	0.00113	CcSEcCtD
Sofosbuvir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000351	0.00113	CcSEcCtD
Sofosbuvir—Dry mouth—Losartan—type 2 diabetes mellitus	0.000349	0.00113	CcSEcCtD
Sofosbuvir—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000346	0.00111	CcSEcCtD
Sofosbuvir—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000344	0.00111	CcSEcCtD
Sofosbuvir—Infection—Losartan—type 2 diabetes mellitus	0.00034	0.0011	CcSEcCtD
Sofosbuvir—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00034	0.00109	CcSEcCtD
Sofosbuvir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000336	0.00108	CcSEcCtD
Sofosbuvir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000335	0.00108	CcSEcCtD
Sofosbuvir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000334	0.00107	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000333	0.00107	CcSEcCtD
Sofosbuvir—Fatigue—Metformin—type 2 diabetes mellitus	0.000333	0.00107	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000332	0.00107	CcSEcCtD
Sofosbuvir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000331	0.00107	CcSEcCtD
Sofosbuvir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000331	0.00107	CcSEcCtD
Sofosbuvir—Agitation—Ramipril—type 2 diabetes mellitus	0.000331	0.00107	CcSEcCtD
Sofosbuvir—Constipation—Metformin—type 2 diabetes mellitus	0.00033	0.00106	CcSEcCtD
Sofosbuvir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000326	0.00105	CcSEcCtD
Sofosbuvir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000326	0.00105	CcSEcCtD
Sofosbuvir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000325	0.00105	CcSEcCtD
Sofosbuvir—Rash—Glyburide—type 2 diabetes mellitus	0.000324	0.00104	CcSEcCtD
Sofosbuvir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000323	0.00104	CcSEcCtD
Sofosbuvir—Headache—Glyburide—type 2 diabetes mellitus	0.000322	0.00104	CcSEcCtD
Sofosbuvir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00032	0.00103	CcSEcCtD
Sofosbuvir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000316	0.00102	CcSEcCtD
Sofosbuvir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000315	0.00102	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000314	0.00101	CcSEcCtD
Sofosbuvir—Cough—Ramipril—type 2 diabetes mellitus	0.000314	0.00101	CcSEcCtD
Sofosbuvir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000314	0.00101	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000312	0.00101	CcSEcCtD
Sofosbuvir—Pain—Irbesartan—type 2 diabetes mellitus	0.000311	0.001	CcSEcCtD
Sofosbuvir—Constipation—Irbesartan—type 2 diabetes mellitus	0.000311	0.001	CcSEcCtD
Sofosbuvir—Insomnia—Losartan—type 2 diabetes mellitus	0.00031	0.000998	CcSEcCtD
Sofosbuvir—Myalgia—Ramipril—type 2 diabetes mellitus	0.000306	0.000987	CcSEcCtD
Sofosbuvir—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000306	0.000987	CcSEcCtD
Sofosbuvir—Chest pain—Ramipril—type 2 diabetes mellitus	0.000306	0.000987	CcSEcCtD
Sofosbuvir—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000305	0.000984	CcSEcCtD
Sofosbuvir—Anxiety—Ramipril—type 2 diabetes mellitus	0.000305	0.000984	CcSEcCtD
Sofosbuvir—Nausea—Glyburide—type 2 diabetes mellitus	0.000305	0.000982	CcSEcCtD
Sofosbuvir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000305	0.000982	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000304	0.00098	CcSEcCtD
Sofosbuvir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000304	0.000979	CcSEcCtD
Sofosbuvir—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000302	0.000971	CcSEcCtD
Sofosbuvir—Asthenia—Orlistat—type 2 diabetes mellitus	0.0003	0.000967	CcSEcCtD
Sofosbuvir—Pruritus—Valsartan—type 2 diabetes mellitus	0.0003	0.000965	CcSEcCtD
Sofosbuvir—Dry mouth—Ramipril—type 2 diabetes mellitus	0.0003	0.000965	CcSEcCtD
Sofosbuvir—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000298	0.000959	CcSEcCtD
Sofosbuvir—Pruritus—Orlistat—type 2 diabetes mellitus	0.000296	0.000954	CcSEcCtD
Sofosbuvir—Fatigue—Losartan—type 2 diabetes mellitus	0.000295	0.000951	CcSEcCtD
Sofosbuvir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000293	0.000944	CcSEcCtD
Sofosbuvir—Constipation—Losartan—type 2 diabetes mellitus	0.000293	0.000944	CcSEcCtD
Sofosbuvir—Pain—Losartan—type 2 diabetes mellitus	0.000293	0.000944	CcSEcCtD
Sofosbuvir—Rash—Gliclazide—type 2 diabetes mellitus	0.000291	0.000936	CcSEcCtD
Sofosbuvir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00029	0.000935	CcSEcCtD
Sofosbuvir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00029	0.000933	CcSEcCtD
Sofosbuvir—Headache—Gliclazide—type 2 diabetes mellitus	0.000289	0.00093	CcSEcCtD
Sofosbuvir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000288	0.000928	CcSEcCtD
Sofosbuvir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000288	0.000927	CcSEcCtD
Sofosbuvir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000286	0.000922	CcSEcCtD
Sofosbuvir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000285	0.000919	CcSEcCtD
Sofosbuvir—Dizziness—Valsartan—type 2 diabetes mellitus	0.00028	0.000902	CcSEcCtD
Sofosbuvir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000277	0.000892	CcSEcCtD
Sofosbuvir—Asthenia—Metformin—type 2 diabetes mellitus	0.000277	0.000891	CcSEcCtD
Sofosbuvir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000274	0.000882	CcSEcCtD
Sofosbuvir—Pruritus—Metformin—type 2 diabetes mellitus	0.000273	0.000879	CcSEcCtD
Sofosbuvir—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000271	0.000872	CcSEcCtD
Sofosbuvir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000269	0.000867	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000268	0.000862	CcSEcCtD
Sofosbuvir—Rash—Valsartan—type 2 diabetes mellitus	0.000267	0.00086	CcSEcCtD
Sofosbuvir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000267	0.000859	CcSEcCtD
Sofosbuvir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000266	0.000857	CcSEcCtD
Sofosbuvir—Insomnia—Ramipril—type 2 diabetes mellitus	0.000266	0.000856	CcSEcCtD
Sofosbuvir—Headache—Valsartan—type 2 diabetes mellitus	0.000265	0.000855	CcSEcCtD
Sofosbuvir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000264	0.00085	CcSEcCtD
Sofosbuvir—Rash—Orlistat—type 2 diabetes mellitus	0.000264	0.00085	CcSEcCtD
Sofosbuvir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000264	0.000849	CcSEcCtD
Sofosbuvir—Headache—Orlistat—type 2 diabetes mellitus	0.000262	0.000845	CcSEcCtD
Sofosbuvir—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000262	0.000844	CcSEcCtD
Sofosbuvir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000261	0.000841	CcSEcCtD
Sofosbuvir—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000259	0.000833	CcSEcCtD
Sofosbuvir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000258	0.00083	CcSEcCtD
Sofosbuvir—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000255	0.000822	CcSEcCtD
Sofosbuvir—Dizziness—Metformin—type 2 diabetes mellitus	0.000255	0.000822	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000254	0.000817	CcSEcCtD
Sofosbuvir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000253	0.000816	CcSEcCtD
Sofosbuvir—Nausea—Valsartan—type 2 diabetes mellitus	0.000252	0.00081	CcSEcCtD
Sofosbuvir—Constipation—Ramipril—type 2 diabetes mellitus	0.000251	0.000809	CcSEcCtD
Sofosbuvir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000249	0.000802	CcSEcCtD
Sofosbuvir—Nausea—Orlistat—type 2 diabetes mellitus	0.000249	0.000801	CcSEcCtD
Sofosbuvir—Asthenia—Losartan—type 2 diabetes mellitus	0.000246	0.000792	CcSEcCtD
Sofosbuvir—Vomiting—Metformin—type 2 diabetes mellitus	0.000245	0.00079	CcSEcCtD
Sofosbuvir—Rash—Metformin—type 2 diabetes mellitus	0.000243	0.000783	CcSEcCtD
Sofosbuvir—Dermatitis—Metformin—type 2 diabetes mellitus	0.000243	0.000783	CcSEcCtD
Sofosbuvir—Pruritus—Losartan—type 2 diabetes mellitus	0.000242	0.000781	CcSEcCtD
Sofosbuvir—Headache—Metformin—type 2 diabetes mellitus	0.000242	0.000778	CcSEcCtD
Sofosbuvir—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000241	0.000775	CcSEcCtD
Sofosbuvir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000234	0.000755	CcSEcCtD
Sofosbuvir—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000232	0.000748	CcSEcCtD
Sofosbuvir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000231	0.000745	CcSEcCtD
Sofosbuvir—Rash—Irbesartan—type 2 diabetes mellitus	0.00023	0.000739	CcSEcCtD
Sofosbuvir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000229	0.000739	CcSEcCtD
Sofosbuvir—Nausea—Metformin—type 2 diabetes mellitus	0.000229	0.000738	CcSEcCtD
Sofosbuvir—Headache—Irbesartan—type 2 diabetes mellitus	0.000228	0.000735	CcSEcCtD
Sofosbuvir—Dizziness—Losartan—type 2 diabetes mellitus	0.000227	0.00073	CcSEcCtD
Sofosbuvir—Vomiting—Losartan—type 2 diabetes mellitus	0.000218	0.000702	CcSEcCtD
Sofosbuvir—Nausea—Irbesartan—type 2 diabetes mellitus	0.000216	0.000696	CcSEcCtD
Sofosbuvir—Rash—Losartan—type 2 diabetes mellitus	0.000216	0.000696	CcSEcCtD
Sofosbuvir—Dermatitis—Losartan—type 2 diabetes mellitus	0.000216	0.000695	CcSEcCtD
Sofosbuvir—Headache—Losartan—type 2 diabetes mellitus	0.000215	0.000691	CcSEcCtD
Sofosbuvir—Asthenia—Ramipril—type 2 diabetes mellitus	0.000211	0.000679	CcSEcCtD
Sofosbuvir—Pruritus—Ramipril—type 2 diabetes mellitus	0.000208	0.000669	CcSEcCtD
Sofosbuvir—Nausea—Losartan—type 2 diabetes mellitus	0.000203	0.000655	CcSEcCtD
Sofosbuvir—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000201	0.000647	CcSEcCtD
Sofosbuvir—Dizziness—Ramipril—type 2 diabetes mellitus	0.000194	0.000626	CcSEcCtD
Sofosbuvir—Vomiting—Ramipril—type 2 diabetes mellitus	0.000187	0.000602	CcSEcCtD
Sofosbuvir—Rash—Ramipril—type 2 diabetes mellitus	0.000185	0.000597	CcSEcCtD
Sofosbuvir—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000185	0.000596	CcSEcCtD
Sofosbuvir—Headache—Ramipril—type 2 diabetes mellitus	0.000184	0.000593	CcSEcCtD
Sofosbuvir—Nausea—Ramipril—type 2 diabetes mellitus	0.000174	0.000562	CcSEcCtD
